Alexandros Ardavanis
- Oncology top 2%
- Cancer Treatment and Pharmacology 38
- HER2/EGFR in Cancer Research 22
- Colorectal Cancer Treatments and Studies 18
- Cancer Immunotherapy and Biomarkers 15
- Peptidase Inhibition and Analysis 10
- Cancer Research top 5%
- Breast Cancer Treatment Studies 14
- Immunology top 5%
- Immunotherapy and Immune Responses 23
- Genetics top 5%
-
- Monoclonal and Polyclonal Antibodies Research 16
- Co-authors
- Andreas ScorilasSonia A. PerezConstantin N. BaxevanisMaroulio TalieriNiki ArnogiannakiMichael PapamichailGerasimos RigatosG. Rigatos
- Cited by
- OncologyCancer ResearchImmunology
- Journals
- Journal of Clinical Oncology (25 papers)Annals of Oncology (9 papers)British Journal of Cancer (4 papers)
- Partner nations
- GreeceUnited StatesGermany
In The Last Decade
Alexandros Ardavanis
127 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 114
- Oncology 1.5k
- Cancer Research 570
- Immunology 640
- Pulmonary and Respiratory Medicine 561
- Genetics 177
Countries citing papers authored by Alexandros Ardavanis
This map shows the geographic impact of Alexandros Ardavanis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandros Ardavanis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandros Ardavanis more than expected).
Fields of papers citing papers by Alexandros Ardavanis
This network shows the impact of papers produced by Alexandros Ardavanis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandros Ardavanis. The network helps show where Alexandros Ardavanis may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alexandros Ardavanis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 7 | |
| 2 | 2022 | 4 | |
| 3 | 2020 | 8 | |
| 4 | 2020 | 1 | |
| 5 | 2020 | 3 | |
| 6 | 2018 | 45 | |
| 7 | 2016 | 80 | |
| 8 | 2015 | 18 | |
| 9 | 2014 | 18 | |
| 10 | 2012 | 14 | |
| 11 | 2010 | 210 | |
| 12 | 2009 | 31 | |
| 13 | Extracellular domain of HER2: a useful marker for the initial workup and follow-up of HER2-positive breast cancer. | 2008 | 11 |
| 14 | 2007 | 84 | |
| 15 | 2005 | 5 | |
| 16 | 2004 | 8 | |
| 17 | 2004 | 41 | |
| 18 | 2004 | 51 | |
| 19 | HER-2/neu overexpression in breast cancer: an immunohistochemical study including correlations with clinicopathologic parameters, p53 oncoprotein and cathepsin-D. | 2001 | 11 |
| 20 | 2001 | 226 |
About Alexandros Ardavanis
Alexandros Ardavanis is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Immunology and Genetics, having authored 133 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (38 papers), Immunotherapy and Immune Responses (23 papers), HER2/EGFR in Cancer Research (22 papers), Colorectal Cancer Treatments and Studies (18 papers), Monoclonal and Polyclonal Antibodies Research (16 papers), Cancer Immunotherapy and Biomarkers (15 papers), Breast Cancer Treatment Studies (14 papers) and Peptidase Inhibition and Analysis (10 papers). The work is most often cited by research in Oncology (1.5k citations), Cancer Research (570 citations), Immunology (640 citations), Pulmonary and Respiratory Medicine (561 citations) and Genetics (177 citations). Alexandros Ardavanis has collaborated with scholars based in Greece, United States and Germany. Frequent co-authors include Andreas Scorilas, Sonia A. Perez, Constantin N. Baxevanis, Maroulio Talieri, Niki Arnogiannaki, Michael Papamichail, Gerasimos Rigatos, G. Rigatos, Theoni Trangas and Christina Economopoulou. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, British Journal of Cancer, Anticancer Research and Tumor Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.